Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Characteristics and Clinical Outcomes of Adult Aplastic Anemia with Abnormal Cytogenetics at Diagnosis.

Sung-Yong Kim, MD., Myungshin Kim, MD, PhD, Kyungja Han, MD, PhD, Seok Lee, MD, PhD, Mark Hong Lee, MD, PhD, Jong-Wook Lee, MD, PhD, Woo-Sung Min, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2008) 112 (11): 2039.

https://doi.org/10.1182/blood.V112.11.2039.2039

Published: 2008

Journal Articles

Predictive Potential of Minimal Residual Disease Level after the First Imatinib Cycle on the Outcome of Allogeneic Stem Cell Transplantation in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Seok Lee, MD, Yoo-Jin Kim, MD, Chang-Ki Min, MD, Byung-Sik Cho, MD, Sung-Yong Kim, MD, Ki-Seong Eom, MD, Heeje Kim, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2007) 110 (11): 1098.

https://doi.org/10.1182/blood.V110.11.1098.1098

Published: 2007

Journal Articles

Overcoming Graft Rejection in Adult Patients with High-Risk Severe Aplastic Anemia Using Supplemental CD34 + -Enriched PBSC in Combination with BM.

Byung-Sik Cho, MD, Sung-Yong Kim, MD, Yoo-Jin Kim, MD, Ki-Seong Eom, MD, Hee-Je Kim, MD, Seok Lee, MD, Chang-Ki Min, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2007) 110 (11): 1111.

https://doi.org/10.1182/blood.V110.11.1111.1111

Published: 2007

Journal Articles

Comparative 2-Arm Study for Acute Graft-Versus-Host Disease; Antithymocyte Globulin Is More Effective Than Mycofenolate Mofetil on Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation from Mismatched Unrelated Donors.

Woo-Sung Min, MD, PhD, Heeje Kim, MD, PhD, Byoung-Sik Cho, MD, Sung-Yong Kim, MD, Ki-Sung Eom, MD, Chang-Ki Min, MD, PhD, Seok Lee, MD, PhD, Jong-Wook Lee, MD, PhD, Chong-Won Park, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2006) 108 (11): 5395.

https://doi.org/10.1182/blood.V108.11.5395.5395

Published: 2006

Journal Articles

Gemtuzumab Ozogamicin in Combination with Attenuated Dose of Standard Induction Chemotherapy Therapy Can Successfully Induce Complete Remission without Increasing Toxicity in Patients with Newly Diagnosed Acute Myeloid Leukemia Aged 55 or Older.

Ki-Seong Eom, MD, Hee-Je Kim, MD, Chang-Ki Min, MD, Seok Lee, MD, Sung-Yong Kim, MD, Byung-Sik Cho, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chong-Won Park, MD, Chun-Choo Kim, MD

Blood (2006) 108 (11): 1982.

https://doi.org/10.1182/blood.V108.11.1982.1982

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation Should Be Performed in First Complete Remission in Adults with Acute Lymphoblastic Leukemia; Strong Antileukemic Activity of Chronic Graft-Versus-Host Disease.

Seok Lee, MD, Byung-Shik Cho, MD, Sung-Yong Kim, MD, Ki-Seong Eom, MD, Yoo-Jin Kim, MD, Chang-Ki Min, MD, Hee-Je Kim, MD, Seok-Goo Cho, MD, Dong-Wook Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Jong-Won Park, MD, Chun-Choo Kim, MD

Blood (2006) 108 (11): 2992.

https://doi.org/10.1182/blood.V108.11.2992.2992

Published: 2006

Journal Articles

Changes in Serum Free Light Chain and Biochemical Markers in Patients with Multiple Myeloma Receiving Bortezomib Treatment.

Chang-Ki Min, MD, Ki-Seong Eom, MD, Seok Lee, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chong-Won Park, MD, Chun-Choo Kim, MD, Myungshin Kim, MD, Jihyang Lim, MD, Yonggoo Kim, MD, Kyungja Han, MD

Blood (2006) 108 (11): 5028.

https://doi.org/10.1182/blood.V108.11.5028.5028

Published: 2006

Journal Articles

High Level of Pretransplant Leukemic Blasts and the Absence of Chronic Graft-Versus-Host Disease Provide Negative Effects on Clinical Outcome of Transplantation with Fludarabine-Busulfex Based Reduced Intensity Conditioning for Patients with the De Novo Myelodysplastic Syndrome According to WHO Criteria.

Seok-Goo Cho, MD, PhD, Byung-Sik Cho, MD, Yoo-Jin Kim, MD, PhD, Sung-Yong Kim, MD, PhD, Ki-Seong Eom, MD, PhD, HeeJe Kim, MD, PhD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Dong-Wook Kim, MD, PhD, Jong-Wook Lee, MD, PhD, Woo-Sung Min, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2006) 108 (11): 4862.

https://doi.org/10.1182/blood.V108.11.4862.4862

Published: 2006

Journal Articles

Immunoregulatory Effects of Allogeneic Mixed Chimerism Induced by T-Cell Depleted, Nonmyeloablative Bone Marrow Transplantation on Chronic Inflammatory Arthritis and Autoimmunity Developed in Interleukin-1 Receptor Antagonist-Deficient Mice.

Seok-Goo Cho, MD, PhD, Min-Chung Park, PhD, So-Youn Min, PhD, Young-Gyu Cho, PhD, Seok Lee, MD, PhD, Mi-La Cho, PhD, Hong-Seok Chang, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Ho-Youn Kim, MD, Chun-Choo Kim, MD

Blood (2005) 106 (11): 1277.

https://doi.org/10.1182/blood.V106.11.1277.1277

Published: 2005

Journal Articles

Outcome of Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia after Conditioning with Procarbazine, ATG and Cyclophosphamide: A Single Center Experience.

Ki Seong, Eom, MD, Jong Wook Lee, MD, Yoo Jin Kim, MD, Hee Je Kim, MD, Chang Ki, Min, MD, Seok Lee, MD, Sung Yong, Kim, MD, Woo Sung, Min, MD, Chun Choo Kim, MD

Blood (2005) 106 (11): 2027.

https://doi.org/10.1182/blood.V106.11.2027.2027

Published: 2005

Journal Articles

Expression of CD25+ Cell Subsets after Induction Chemotherapy in Adult Patients with Acute Myeloid Leukemia.

Woo-Sung Min, MD, PhD, Hee-Je Kim, MD, PhD, Young Choi, MD, PhD, Sung-Yong Kim, MD, Ki-Sung Eom, MD, Yoo-Jin Kim, MD, PhD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Jong-Wook Lee, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2005) 106 (11): 4597.

https://doi.org/10.1182/blood.V106.11.4597.4597

Published: 2005

Journal Articles

Mobilization of Stem Cells from the Bone Marrow Is Required for Neovascularization of Ischemic Limbs in Mice.

Jeong-A Kim, MD, Chang -Hoon Lee, Ms, Jin-A. Yoon, BS, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2005) 106 (11): 4233.

https://doi.org/10.1182/blood.V106.11.4233.4233

Published: 2005

Journal Articles

Monitoring of BCR-ABL Transcirpt Levels after Discontinuation of Imatinib Therapy in Chronic Myelogenous Leukemia Patients Achieving Complete Cytogenetic Response.

Yoo-Jin Kim, MD, Dong-Wook Kim, MD, Seok Lee, MD, Ki-Seong Eom, MD, Chang-Ki Min, MD, Hee-Je Kim, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chun-choo Kim, MD

Blood (2004) 104 (11): 4684.

https://doi.org/10.1182/blood.V104.11.4684.4684

Published: 2004

Journal Articles

Optimal TBI Dose to Improve the Survival in Unrelated Matched Marrow Transplantation for Adult Patients with Severe Aplastic Anemia: Prospective De-Escalation Study of TBI Dose.

Jong-Wook Lee, MD, Ki Seong Eom, MD, Yoon Hee Park, MD, Yoo Jin Kim, MD, Seok Lee, MD, Chang Ki Min, MD, Hee Je Kim, MD, Dong Wook Kim, MD, Jong Youl Jin, MD, Woo Sung Min, MD, Chong Won Park, MD, Chun Choo Kim, MD

Blood (2004) 104 (11): 2770.

https://doi.org/10.1182/blood.V104.11.2770.2770

Published: 2004

Journal Articles

Long-Term Pre-Transplant Imatinib Can Improve the Outcome of Non-Myeloablative Stem Cell Transplantation without Increasing the Morbidity in Ph+ Chronic Myeloid Leukemia.

Dong-Wook Kim, MD, Ki-Seong Eon, MD, Yoo-Jin Kim, MD, Hee-Je Kim, MD, Chang-Ki Min, MD, Jong-Wook Lee, MD, Woo-Sung Min, MD, Chun-Choo Kim, MD

Blood (2004) 104 (11): 5043.

https://doi.org/10.1182/blood.V104.11.5043.5043

Published: 2004

Journal Articles

Pretreatment Serum Soluble Interleukin-2 Receptor Levels Predict the Response after Immunosuppressive Therapy of Aplastic Anemia.

Chang-Ki Min, MD, Jong-Wook Lee, MD, Woo Sung Min, MD, Chun Choo Kim, MD, Myungshin Kim, MD, Jihyang Lim, MD, Yonggoo Kim, MD, Kyungja Han, MD

Blood (2004) 104 (11): 4219.

https://doi.org/10.1182/blood.V104.11.4219.4219

Published: 2004

NARROW

Characteristics and Clinical Outcomes of Adult Aplastic Anemia with Abnormal Cytogenetics at Diagnosis.

Predictive Potential of Minimal Residual Disease Level after the First Imatinib Cycle on the Outcome of Allogeneic Stem Cell Transplantation in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Overcoming Graft Rejection in Adult Patients with High-Risk Severe Aplastic Anemia Using Supplemental CD34 + -Enriched PBSC in Combination with BM.

Comparative 2-Arm Study for Acute Graft-Versus-Host Disease; Antithymocyte Globulin Is More Effective Than Mycofenolate Mofetil on Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation from Mismatched Unrelated Donors.

Gemtuzumab Ozogamicin in Combination with Attenuated Dose of Standard Induction Chemotherapy Therapy Can Successfully Induce Complete Remission without Increasing Toxicity in Patients with Newly Diagnosed Acute Myeloid Leukemia Aged 55 or Older.

Allogeneic Stem Cell Transplantation Should Be Performed in First Complete Remission in Adults with Acute Lymphoblastic Leukemia; Strong Antileukemic Activity of Chronic Graft-Versus-Host Disease.

Changes in Serum Free Light Chain and Biochemical Markers in Patients with Multiple Myeloma Receiving Bortezomib Treatment.

Immunoregulatory Effects of Allogeneic Mixed Chimerism Induced by T-Cell Depleted, Nonmyeloablative Bone Marrow Transplantation on Chronic Inflammatory Arthritis and Autoimmunity Developed in Interleukin-1 Receptor Antagonist-Deficient Mice.

Outcome of Allogeneic Stem Cell Transplantation for Patients with Severe Aplastic Anemia after Conditioning with Procarbazine, ATG and Cyclophosphamide: A Single Center Experience.

Expression of CD25+ Cell Subsets after Induction Chemotherapy in Adult Patients with Acute Myeloid Leukemia.

Mobilization of Stem Cells from the Bone Marrow Is Required for Neovascularization of Ischemic Limbs in Mice.

Monitoring of BCR-ABL Transcirpt Levels after Discontinuation of Imatinib Therapy in Chronic Myelogenous Leukemia Patients Achieving Complete Cytogenetic Response.

Optimal TBI Dose to Improve the Survival in Unrelated Matched Marrow Transplantation for Adult Patients with Severe Aplastic Anemia: Prospective De-Escalation Study of TBI Dose.

Long-Term Pre-Transplant Imatinib Can Improve the Outcome of Non-Myeloablative Stem Cell Transplantation without Increasing the Morbidity in Ph+ Chronic Myeloid Leukemia.

Pretreatment Serum Soluble Interleukin-2 Receptor Levels Predict the Response after Immunosuppressive Therapy of Aplastic Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only